← FDA Drug Approvals (Drugs@FDA)

CARFILZOMIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-11-25

Drug application

FDA Application #

ANDA210823

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARFILZOMIB

Generic name

Carfilzomib

Active ingredients

CARFILZOMIB

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

None (Tentative Approval)

Sponsor

EUGIA PHARMA

First approval

2022-11-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown